INVOS™ 7100 cerebral oximetry system
 

Insight.
Earlier.
Anywhere.

 

The INVOS™ 7100 regional oximetry system gives you a "first alert" to changes in tissue oxygenationthat, if left untreated, could quickly impact the course of precious pediatric and neonatal patients' lives.2,3

Get alerts to changes in perfusion before other vital signs.

While blood pressure and pulse oximetry monitoring provide critical information, they don’t give you a complete picture of tissue perfusion and oxygenation.4

Near-infrared Spectroscopy (NIRS) monitoring with the INVOS™ 7100 system gives you an early insight when a change in perfusion is occurring, before other vital signs may indicate there is an issue.1,5

Unlike pulse oximetry, which measures arterial oxygen, the INVOS™ 7100 system measures rSO2, a reflection of cerebral venous saturation4 detecting hemodynamic changes and deteriorating patient conditions when timely intervention is critical.1,4

Stay ahead of rapidly changing conditions for neonates and children

Accurate assessment of adequacy of tissue oxygenation status is a clinical challenge in neonatal and pediatric patient populations5 and in the vulnerable group of neonates, abnormal oxygenation and/or perfusion patterns often precede brain damage. 6

The INVOS™ 7100 is intended to be used as an adjunct monitor of regional hemoglobin saturation of blood in the brain or other tissues beneath the sensor.1 and provides tissue-specific clinical monitoring that measures oxygenation adequacy and balance of oxygen availability1 alerting you of trend changes, when seconds matter 1,5

INVOS™ regional oximetry guided care resulted in:
49

fewer mean hours on a ventilator10

28%

less need for controlled ventilation10

54%

less need for inspired nitrogen10

Monitor organ-specific perfusion anywhere on the body from any location within your hospital.

Continuous monitoring with the INVOS™ 7100 regional oximetry system gives you a comprehensive picture of organ-specific tissue oxygenation anywhere on the body, giving you an early warning of developing issues.1 The portable, lightweight tablet-style monitor is easy to move with the patient to any intrahospital location, allowing you to maintain continuous monitoring.7

The INVOS™ 7100 regional oximetry monitoring system:

  • Provides continuous, noninvasive readings of organ-specific regional blood oxygen levels in up to four site specific areas chosen by the care team.7
  • Provides oxygen saturation from vascular beds to assess organs individually, or in combination to track brain/body perfusion shifts.4
  • The enhanced system has the performance clinicians rely on along with design upgrades using feedback from customers around the world, including an intuitive interface that’s easy to use. Monitor organ-specific perfusion anywhere on the body from any location within your hospital.8,9

Clinical evidence

Your tiniest patients can be the most vulnerable, so you want technology you trust. INVOS™ technology has set the clinical reference standard in regional oximetry. In fact, when it comes to clinical evidence, no other regional oximeter is backed by a comparable volume of published, peer-reviewed research. 

Hemodynamic impact of mechanical ventilation on neonates

Monitoring premature neonates 
 

Pediatric cardiac critical care 
 

Monitoring organ perfusion in the NICU after hypoxicischemic encephalopathy (HIE)

Cannula position during atrial septal defect (ASD) repair
 

Curious about how INVOS™ 7100 regional oximetry system can help your most vulnerable pediatric and neonatal patients?

Fill out the form below and we will reach out as soon as possible for a free demo or additional information

Contact us
References

The INVOS™ 7100 Cerebral Oximetry System should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.

1. Avery EG. Cerebral oximetry is frequently a “first alert” indicator of adverse outcomes. Internal white paper 2010

2. Saikia D, Mahanta B. Cardiovascular and respiratory physiology in children. Indian J Anaesth. 2019;63(9):690-697.

3. Plomgaard AM, Alderliesten T, Austin T, et al. Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial. PLoS One. 2017;12(3):e0173440.

4. Tobias JD. Cerebral oximetry monitoring with near infrared spectroscopy detects alterations in oxygenation before pulse oximetry. J Intensive Care Med. 2008;23(6):384-388. https://pubmed.ncbi.nlm.nih.gov/18794168

5. Lu Y, Di M, Li C, Chen M, Yuan K, Shangguan W. Comparing the response of pulse oximetry and regional cerebral oxygen saturation to hypoxia in preschool children. Exp Ther Med. 2020;19(1):353-358. https://pubmed.ncbi.nlm.nih.gov/31853311

6. Costa FG, Hakimi N, Van Bel F. Neuroprotection of the Perinatal Brain by Early Information of Cerebral Oxygenation and Perfusion Patterns. Int J Mol Sci. 2021 May 20;22(10):5389. doi: 10.3390/ijms22105389. PMID:34065460; PMCID: PMC8160954.

7. IFU PT00121768 Rev C: The INVOS™ Patient Monitor, model PM7100, is a noninvasive regional oximetry system intended for use as an adjunct monitor of regional hemoglobin saturation of blood in brain or in other tissue beneath the sensor.

8. Based on internal report #10124168 User Interface Specification

9. Based on internal report RE00120556 HF Validation report

10. Johnson BA, Hoffman GM, Tweddell JS, et al. Near-infrared spectroscopy in neonates before palliation of hypoplastic left heart syndrome. Ann Thorac Surg. 2009;87(2):571-577.

11. Yu Y, Zhang K, Zhang L, Zong H, Meng L, Han R. Cerebral near‐infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults. Cochrane Database of Systematic Reviews. 2018(1). DOI: 10.1002/14651858.CD010947.pub2